Teva

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

In the last 7 days

European Commission Fines Teva €462.6 Million for Misusing Divisional patents and Disparaging Generic Competitors in… JD Supra15:26 17-Apr-25

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals Zacks10:44 16-Apr-25

In the last month

3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes Zacks13:20 15-Apr-25

Fed. Circ. Hears Teva Challenge To J&J Schizophrenia Drug Law36001:38 15-Apr-25

Teva, Viatris Press to Break J&J’s Hold on Schizophrenia Drug Bloomberg Law20:11 14-Apr-25

Validea Detailed Fundamental Analysis - TEVA Nasdaq19:43 14-Apr-25

Teva Agrees to End Inhaler-Patents Case Over Deva’s ProAir Copy Bloomberg Law21:15 11-Apr-25

Teva and Samsung Bioepis Announce U.S. Launch of EPYSQLI® (eculizumab-aagh), a SOLIRIS® Biosimilar JD Supra15:03 10-Apr-25

Teva and Samsung Bioepis Launch Biosimilar Epysqli Center for Biosimilars21:57 9-Apr-25

Samsung Bioepis launches Soliris biosimilar in US through Teva Korea Biomedical Review02:08 8-Apr-25

Teva and Samsung Bioepis Announce Biosimilar Epysqli® (eculizumab-aagh) Injection Now Available in the United States GlobeNewswire (Press Release)13:06 7-Apr-25

Teva Announces FDA Filing Acceptance for Ajovy® (fremanezumab) in Pediatric Episodic Migraine Prevention GlobeNewswire (Press Release)12:36 7-Apr-25

Chaco Vs. Teva Sandals Comparison Review Prevention.com22:42 31-Mar-25

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 Solaris Trial Survey Results Demonstrating… GlobeNewswire (Press Release)18:08 31-Mar-25

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now The Motley Fool10:12 28-Mar-25

Teva Pharmaceutical Indus Unusual Options Activity Nasdaq20:42 27-Mar-25

Teva Releases Q1 2025 Aide Memoire GlobeNewswire (Press Release)20:38 27-Mar-25

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025 GlobeNewswire (Press Release)20:38 27-Mar-25

AG Rantos: Teva pay-for-delay appeal should not survive ECJ scrutiny Global Competition Review18:35 27-Mar-25

Top EU Court Urged To Uphold €60M Teva Pay-For-Delay Fine Law36016:25 27-Mar-25

Advocate General opinion on appeal by Teva and Cephalon against General Court judgment that upheld Commission decision… Thomson Reuters - Practical Law15:43 27-Mar-25

Hasbro unveils new Star Wars: The Vintage Collection and Black Series action figures Flickering Myth23:11 26-Mar-25

view more headlines

17 Apr 15:26

Teva News

NewsNow brings you the latest news from the world’s most trusted sources on Teva. NewsNow aims to be the world’s most accurate and comprehensive Teva news aggregator, bringing you the latest headlines automatically and continuously 24/7.

Teva

Teva News

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories